AstraZeneca’s Farxiga Fails To Get FDA OK As Insulin Supplement In Type 1 Diabetes

 
• By Sten Stovall
Laptop
The FDA’s CRL will have said the Farxiga application cannot be approved in its present form • Source: Shutterstock

More from New Products

More from Scrip